COMPANY
ILIAD Biotechnologies
Funding and NIH signals
- SEC Form D raise Raised $115.54M (Form D filed Feb 20, 2026). SEC Form D 0002112659-26-000001 (Feb 20, 2026)
Evidence (1 event)
- Feb 20, 2026 · SEC Form D 0002112659-26-000001
Name of Issuer: ILIAD BIOTECHNOLOGIES, INC.; CIK: 2112659; Address: Weston, FL; Submission type: D; Filing date: 2026-02-20; Industry Group: Biotechnology; Date of First Sale: 2026-02-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 115540057; Total Amount Sold: 115540057; Federal exemptions: 06b
- Feb 20, 2026 · SEC Form D 0002112659-26-000001